Applications of Biotechnology in Cardiovascular Therapeutics [recurso electrónico] / by Kewal K. Jain.

Por: Jain, Kewal K [author.]Colaborador(es): SpringerLink (Online service)Tipo de material: TextoTextoEditor: Totowa, NJ : Humana Press, 2011Descripción: XXVIII, 350p. 13 illus. online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9781617792403Tema(s): Chemistry | Biotechnology | Chemistry | BiotechnologyFormatos físicos adicionales: Printed edition:: Sin títuloClasificación CDD: 660.6 Clasificación LoC:TP248.13-248.65Recursos en línea: Libro electrónicoTexto
Contenidos:
Cardiovascular Therapeutics -- Drug Delivery to the Cardiovascular System -- Role of Nitric Oxide in Cardiovascular Disorders -- Biomarkers of Cardiovascular Disorders -- Molecular Diagnosis of Cardiovascular Disorders -- Nanobiotechnology in Cardiovascular Disorders -- Cell Therapy for Cardiovascular Disorders -- Gene Therapy for Cardiovascular Disorders -- Coronary Angioplasty & Drug-Eluting Stents -- Personalized Cardiology.
En: Springer eBooksResumen: For physicians, surgeons, and scientists working on cardiovascular disorders, Applications of Biotechnology in Cardiovascular Therapeutics serves as an invaluable reference by collecting the essential writings of Dr. Kewal K. Jain on the topics of biotechnology as they relate to cardiovascular disease.  This thorough volume includes such subjects as biotechnology and therapeutic delivery to the cardiovascular system, cell-selective targeted drug delivery, cell and gene therapies, including antisense and RNA interference, cutting-edge gene therapy approaches, as well as personalized cardiology as a way of integrating new technologies into the selection of the best possible treatment for an individual patient.  Selected references from recent literature are collected for each chapter, and the text is supplemented by a variety of useful tables and figures.   Comprehensive and up-to-date, Applications of Biotechnology in Cardiovascular Therapeutics will be tremendously useful for those working in life sciences and the pharmaceutical sciences, and the inclusion of some basics of cardiovascular diseases will greatly benefit nonmedical readers as well.
Star ratings
    Valoración media: 0.0 (0 votos)
Existencias
Tipo de ítem Biblioteca actual Colección Signatura Copia número Estado Fecha de vencimiento Código de barras
Libro Electrónico Biblioteca Electrónica
Colección de Libros Electrónicos TP248.13 -248.65 (Browse shelf(Abre debajo)) 1 No para préstamo 372664-2001

Cardiovascular Therapeutics -- Drug Delivery to the Cardiovascular System -- Role of Nitric Oxide in Cardiovascular Disorders -- Biomarkers of Cardiovascular Disorders -- Molecular Diagnosis of Cardiovascular Disorders -- Nanobiotechnology in Cardiovascular Disorders -- Cell Therapy for Cardiovascular Disorders -- Gene Therapy for Cardiovascular Disorders -- Coronary Angioplasty & Drug-Eluting Stents -- Personalized Cardiology.

For physicians, surgeons, and scientists working on cardiovascular disorders, Applications of Biotechnology in Cardiovascular Therapeutics serves as an invaluable reference by collecting the essential writings of Dr. Kewal K. Jain on the topics of biotechnology as they relate to cardiovascular disease.  This thorough volume includes such subjects as biotechnology and therapeutic delivery to the cardiovascular system, cell-selective targeted drug delivery, cell and gene therapies, including antisense and RNA interference, cutting-edge gene therapy approaches, as well as personalized cardiology as a way of integrating new technologies into the selection of the best possible treatment for an individual patient.  Selected references from recent literature are collected for each chapter, and the text is supplemented by a variety of useful tables and figures.   Comprehensive and up-to-date, Applications of Biotechnology in Cardiovascular Therapeutics will be tremendously useful for those working in life sciences and the pharmaceutical sciences, and the inclusion of some basics of cardiovascular diseases will greatly benefit nonmedical readers as well.

19

Con tecnología Koha